Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

P-1075

Copy Product Info
🥰Excellent
Catalog No. T16420Cas No. 60559-98-0

P-1075 is a potent sulfonylurea receptor 2-associated ATP-sensitive potassium channels (SUR2-KIR6) activator (EC50 = 45 nM). P-1075 opens opens mitoKATP channels and may be cardioprotective.

P-1075

P-1075

Copy Product Info
🥰Excellent
Purity: 99.85%
Catalog No. T16420Cas No. 60559-98-0
P-1075 is a potent sulfonylurea receptor 2-associated ATP-sensitive potassium channels (SUR2-KIR6) activator (EC50 = 45 nM). P-1075 opens opens mitoKATP channels and may be cardioprotective.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$55In StockIn Stock
5 mg$128In StockIn Stock
10 mg$213In StockIn Stock
25 mg$388In StockIn Stock
50 mg$589In StockIn Stock
100 mg$787In StockIn Stock
200 mg$1,070In StockIn Stock
1 mL x 10 mM (in DMSO)$97In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:99.85%
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

P-1075 AI Summary
P-1075 exhibits diverse bioactivities, including ionization constants with pKa1 at 2.61 and pKa2 at 12.18. It shows potent bioactivity in various assays: it induces a 15% increase in [86Rb+] efflux from rat portal vein at a concentration with a pEC15 of 7.4, inhibits spontaneous activity with an IC50 of 1.995 nM, and has binding affinities with a Ki of 27.0 nM in canine cardiac membranes and a Hill coefficient of 1.17. It requires an EC50 of 60.0 nM to delay contracture onset in ischemic rat hearts and shows inhibition of methoxamine-induced contractions in rat aorta with an IC50 of 4.4 nM. Additionally, it modulates K-ATP channels, with EC50 values of 44.67 nM and 85.11 nM in guinea pig and landrace pig bladder assays, respectively, and shows vasorelaxant activity in rat aorta (IC50 250.0 nM), though it is weakly active against rat mitochondrial ATP hydrolase (IC50 > 100,000 nM). P-1075 displays hypotensive effects, effective at doses as low as 0.1 mg/kg, but is toxic at higher doses (LD50 14 mg/kg). It also exhibits antibacterial and antiviral properties, showing various inhibition percentages against pathogens and high IC50 values (>20,000 nM) for SARS-CoV-2 antiviral activity. Lastly, it has a complex impact on cell viability, enhancing growth in some cell lines while suppressing it in others..
Note: Summary generated by AI. Data source: ChEMBL
Bioactivity
Description
P-1075 is a potent sulfonylurea receptor 2-associated ATP-sensitive potassium channels (SUR2-KIR6) activator (EC50 = 45 nM). P-1075 opens opens mitoKATP channels and may be cardioprotective.
Targets&IC50
SUR2-KIR6:45 nM(EC50)
Chemical Properties
Molecular Weight231.3
FormulaC12H17N5
Cas No.60559-98-0
SmilesCCC(C)(C)N\C(NC#N)=N\c1cccnc1
Relative Density.1.07 g/cm3 (Predicted)
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 250 mg/mL (1080.85 mM), Sonication is recommended.
In Vivo Formulation
10% DMSO+40% PEG300+5% Tween 80+45% Saline: 5 mg/mL (21.62 mM), Sonication is recommended.
Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM4.3234 mL21.6169 mL43.2339 mL216.1695 mL
5 mM0.8647 mL4.3234 mL8.6468 mL43.2339 mL
10 mM0.4323 mL2.1617 mL4.3234 mL21.6169 mL
20 mM0.2162 mL1.0808 mL2.1617 mL10.8085 mL
50 mM0.0865 mL0.4323 mL0.8647 mL4.3234 mL
100 mM0.0432 mL0.2162 mL0.4323 mL2.1617 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy P-1075 | purchase P-1075 | P-1075 cost | order P-1075 | P-1075 chemical structure | P-1075 formula | P-1075 molecular weight